Legacy Wealth Management (Idaho)’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-41
Closed -$3.55K 636
2026
Q1
$3.55K Buy
41
+11
+37% +$1.05K ﹤0.01% 684
2025
Q4
$2.88K Hold
30
﹤0.01% 621
2025
Q3
$2.86K Hold
30
﹤0.01% 502
2025
Q2
$2.62K Hold
30
﹤0.01% 471
2025
Q1
$2.7K Sell
30
-54
-64% -$4.83K ﹤0.01% 498
2024
Q4
$7.56K Buy
84
+54
+180% +$4.67K ﹤0.01% 333
2024
Q3
$2.64K Buy
+30
New +$2.52K ﹤0.01% 459

Other funds holding MDT

Legacy Wealth Management (Idaho)'s MDT Position: Q2 2026 in Review

Legacy Wealth Management (Idaho) sold out of Medtronic (MDT) in Q2 2026, closing a stake of 41 shares — an estimated $3.55K sold.

Legacy Wealth Management (Idaho) first reported a position in MDT in Q3 2024 and held it in 7 quarters. The position peaked at $7.56K in Q4 2024. 2,123 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Legacy Wealth Management (Idaho) reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Legacy Wealth Management (Idaho) sold 41 Medtronic shares in Q2 2026, an estimated $3.55K.
  • Legacy Wealth Management (Idaho) first reported a position in Medtronic in Q3 2024 and held it in 7 quarters.
  • Legacy Wealth Management (Idaho)'s Medtronic position peaked at $7.56K in Q4 2024.
  • 2,123 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Legacy Wealth Management (Idaho)'s 13F filing for Q2 2026, filed 13 Aug 2026.